The usefulness of GHRP-2 test in patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

JRCT ID: jRCTs021180040

Registered date:26/03/2019

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma
• Date of first enrollment: 31/05/2019
• Target sample size: 55
• Study type: Interventional
• Intervention(s): administration of GHRP-2

Outcome(s)

• Primary Outcome: Serum TSH, GH and prolactin levels after administration of GHRP-2
• Secondary Outcome: none

Key inclusion & exclusion criteria

• Age minimum: >= 15age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma
• Exclude criteria: Allergy to GHRP-2

Related Information

• Primary Sponsor: Kageyama Kazunori